News

Liver Disease

Genfit Updates Market on Clinical Progress; Phase 3 on Track for Chronic Liver Disease (PBC)

Edward Kim | Equities.com |

At current levels, the stock is trading for its cash value.


Novo Nordisk To Acquire Dicerna Pharmaceuticals for $3.3 Billion

Kimberly Redmond | Equities.com |

Danish drugmaker Novo Nordisk A/S plans to buy US-based biotech Dicerna Pharmaceuticals Inc in a $3.3 billion cash deal.

Under the terms of the agreement announced Thursday, Novo will pay $38.25 per share in cash, an 80% premium to Dicerna’s closing price on Nov. 17. https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=87435 

Based in Lexington, Massachusetts, Dicerna’s drug development has...


Three Scientists Win Nobel Prize for Medicine for Discovery of Hepatitis C Virus

AP News | Equities.com |

Americans Harvey J. Alter and Charles M. Rice and British-born scientist Michael Houghton jointly won the Nobel Prize for medicine on Monday for their discovery of the hepatitis C virus, a major source of liver disease that affects millions worldwide.

Announcing the prize, the Nobel Committee noted that the trio’s work identified a major source of blood-borne hepatitis that couldn’t be explained by the previously discovered hepatitis A and B viruses. Their...


Sponsored Financial Content

Market Movers